Recent in Updates by Region (page 26 of 28)

Ayurvedic Products Ruled Medicines, Not Cosmetics

Products containing medicinal content and aimed at curing certain ailments will be classified as medicaments and not cosmetics, according to a court ruling in New Delhi...

CTPA Says Review Paper on AP/Deo, Breast Cancer Should Not Cause Alarm

A recent paper calling for further research into the alleged link between aluminium salts in antiperspirants and breast cancer should not constitute alarm, said the CTPA.

AAD Responds to FDA Labeling Decision on Eczema Medications
[Feb. 21, 2006]

The American Academy of Dermatology (AAD) recently issued a statement in response to the U.S. Food and Drug Administration’s (FDA) decision that a black box warning be added to labels...

FDA Commissions Study of its Drug, Biologics Application Processes

The U.S. Food and Drug Administration (FDA) released a new report that examines the way the agency reviews applications for drugs and biologics that have not previously been approved by the FDA.

Dermatology Association Urges FDA to Postpone Program for Isotretinoin Patients

Patient safety while taking isotretinoin depends on the careful oversight of the prescriber, according to the American Academy of Dermatology Association.

Foamix Awarded American, Australian Patents for Delivery Technology

Foamix Ltd. announced it has received two separate patents for its delivery system/carrier technology.

EU to Move Forward with Research Funding Program

The leaders of the European Union (EU) reportedly plan to move forward making a decision regarding the region's R&D funding program.

Regulatory Review--United States Update

California’s Safe Cosmetic Act Well, he did it. In October Governor Arnold Schwarzenegger signed into law the California Safe Cosmetic Act of 2005. As reported in my last column, this new law will not make cosmetics safer than they are now, but will increase costs for cosmetic companies and the taxpayers of the State of California while accomplishing absolutely nothing.

European Commission Approves Fentanyl HCl Iontophoretic Transdermal System

The European Commission has granted marketing authorization in the 25 member states of the European Union for the use of Fentanyl hydrochloride (HCl) Iontophoretic Transdermal System (ITS) 40 mcg/dose...

EUROPEN Publishes Packaging Standards Guide

EUROPEN has published a new edition of its guide to assist personal care manufacturers with packaging standards and regulations.

The 7th International Conference on Cosmetic Regulations

On October 20-22, 2003, more than 300 delegates gathered at the Le Meridien Grand Pacific Hotel on Tokyo Bay for the 7th International Conference on Cosmetic Regulations. Every three years, U.S., EU and Japanese trade associations for the cosmetic industry sponsor this meeting in order to gain mutual understanding and work toward harmonizing global regulations of cosmetics. There were no spectacular announcements, unlike the last conference in 2000 in Malta when Japan announced significant changes in their cosmetic regulations.

European Adaptation to Technical Progress

Starting with January 2003, The European Union discontinued the numbering of their Adaptation to Technical Progress (ATP). This was done as the 7th Amendment superceded some of the approved ATP’s and made the numbering system out of sync. Since I last reported on the 7th Amendment changes, the EU Commission has issued two critical changes. ATP’s are the way to change the Annexes in the Cosmetic Directive.

Can't find what you're looking for? Try searching, or looking through past issues.